We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Pets At Home Group Plc | LSE:PETS | London | Ordinary Share | GB00BJ62K685 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.40 | -0.14% | 283.00 | 282.80 | 283.80 | 285.40 | 280.00 | 280.00 | 619,519 | 16:35:06 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 1.4B | 100.7M | 0.2114 | 13.40 | 1.35B |
From Apr 2019 to Apr 2024
TIDMPETS
RNS Number : 7964O
Pets At Home Group Plc
22 May 2018
22 MAY 2018, THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
Pets at Home Group Plc: Preliminary Results FY18
for the 52 week period to 29 March 2018
Back on a stronger competitive footing
Hot Features
Premium
GBPm FY17 FY18 Change
Group like-for-like revenue growth(#) 1.5% 5.5%
Merchandise LFL(#) 0.8% 5.0%
Services & other LFL(#) 7.9% 8.5%
Group revenue 834.2 898.9 7.8%
Merchandise revenue 716.7 765.4 6.8%
Services & other revenue 117.5 133.5 13.7%
Group gross margin 54.2% 51.7% (249) bps
Underlying profit before tax(a, #) 96.4 84.5 (12.3)%
Statutory profit before tax 95.4 79.6 (16.6)%
Free cashflow(#) 64.6 55.8 (13.6)%
a. Non-underlying items in FY18 include GBP2.7m associated with the closure of Barkers, GBP1.6m accounting charge for the acquisition of minority stakes owned by vet partners in Specialist Referral Centres, and GBP0.6m of other expenses. Non-underlying items in FY17 include GBP1.0m of expenses for the disposal of Farm Away Limited, the Group's equestrian retailing business.
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
-- Strong trading in Merchandise with FY18 like-for-like revenue(#) growth of 5.0% (Q4 LFL(#) : 7.5%) and market share gains in food and accessories
-- Omnichannel revenues(#) of GBP51.4m grew at 75.1%, ahead of the online pet market and key competitors
-- Total fee income from First Opinion Joint Venture vet practices up 16.1% to GBP53.1m and double digit revenue growth in Specialist Referral Centres
-- Group PBT position: reflects our cGBP13m price investment in Merchandise, which remains on track and is delivering positive results faster than expected, and a GBP5.0m increase in the provision held for practice loans in our veterinary business
-- Net openings completed: 13 superstores, 25 vet practices and 27 grooming salons. Closed seven Barkers stores as previously announced
-- Total dividend payable of 7.5 pence per share, maintained at the prior year level
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Peter Pritchard, Group Chief Executive Officer, commented:
"I'm proud and excited to be taking over as CEO. The value of our business is much greater than being a retailer, or a vet care provider. It's the way we can give pet owners a breadth of products, grooming, vet care and other services. Combined with the way we can serve them through stores, the website and our pet professionals, the colleagues and vets who genuinely care about customers and their pets.
Our plans to reposition retail are working, more customers are coming back to shop with us, and we are committed to returning the business to profit growth. But it hasn't been easy. We took decisive action, threw passion and energy into it, and delivered targeted pricing changes to give customers the products that mattered most to them, with the service and value they expect from us. Our product innovation this year has been the best I can remember and the investment we made in the development of a subscription service is bringing some excellent results, as is Order In-Store, which brings our full online range to every store in the business.
The veterinary services market is a very attractive space in which we can grow. We have a profitable business delivering strong returns, achieved largely through our preference to work in partnership with vets who share in the success of their practice. The shortage of qualified vets in the UK remains an industry wide problem, so we have chosen to slow our practice rollout to be sure we open practices in quality locations for the best vet partners. With slower rollout we can, and need to, focus more on strategies to accelerate growth in our existing practices, where we know there is still huge potential. About 84%(b) of our First Opinion practices are relatively young and whilst they require more funding from us over the next 4-5 years, the long-term prize for us and our vet partners is substantial.
We have a bright future. Year one of our three-year strategy has delivered, and as a business we are on a stronger competitive footing to return to sustainable profit growth. But the job isn't done yet. As our new CEO, my plan has a bigger focus on digital, tapping into the vast potential of our customer and pet data, and taking action to ensure our vet business reaches its potential. Our market has a track record of resilience in a downturn and as we adapt to a changing environment, we will emphasise the things that make Pets at Home unique and best placed to serve the UK's pet loving owners."
b. Refers to vet practices younger than 10 years
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Outlook and guidance
The pet care market remains resilient, with growth in pet products estimated at c2% in 2017, and veterinary services at c5%. We again grew our market share in the vet segment and are pleased to say that following our price repositioning work in retail, we have won back share in the food and accessories markets.(c)
FY19 will be the second of our three year financial transition back to sustainable profit growth, and following our progress in FY18, we are determined to achieve our plan. In the coming financial year we are targeting like-for-like revenue growth ahead of the market in both Retail and our Vet Group, and a transition back to low single digit underlying Group profit(#) growth. We remain a cash generative business with a priority to invest in our core capabilities, particularly our Vet Group.
c. Market information sourced using internal data and UK pet market reports
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
FY19 guidance
-- Rollout: up to five superstores, 20-25 vet practices, 10-20 grooming salons
-- Group gross margin down (75-125) bps, reflecting the annualisation of last years price investment, mitigated by the growing margin of our vet business
-- Underlying operational cost(#) growth (excluding depreciation and amortisation) of 3-3.5% -- Depreciation and amortisation GBP37-38m -- Net interest GBP3-3.5m -- Effective tax rate 20% -- Capital investment GBP39-41m -- Group working capital outflow of cGBP20m to support vet practice growth -- Intention to maintain ordinary dividend payment at the prior year level
-- Non-underlying items: accounting treatment of the minority stakes owned by vet partners in the Specialist Referral Centres is likely to lead to a non cash operating expense charge of GBP1.5-2m. See page 12 for further detail
New financial reporting disclosure
In FY19 our financial reporting will change to two segments that better represent the size of the respective businesses and our internal reporting structures; Retail (includes products purchased online and in-store, pet sales and grooming services) and Vet Group (includes our First Opinion practices and Specialist Referral Centres). In order to familiarise readers of the accounts, and provide a basis for comparability, we show a pro-forma unaudited segmentation for the 52 weeks to 29 March 2018.
GBPm Retail Vet Group Central costs Total Group LFL revenue growth (#) 4.6% 15.0% 5.5% Revenue 804.9 94.1 898.9 Gross margin 52.2% 47.1% 51.7% Underlying EBITDA(#) 97.3 (d) 31.9 (e) (5.8) 123.3 Underlying EBIT(#) 65.1 (d) 29.6 (e) (5.8) 88.8
d. Non-underlying items: GBP2.7m associated with the closure of Barkers
e. Non-underlying items: GBP1.6m accounting charge for the acquisition of minority stakes owned by vet partners in Specialist Referral centres, and GBP0.6m of other expenses
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Board appointments
Tessa Green, Independent Non-Executive Director, has decided to step down from the Board at the Annual General Meeting on 12 July 2018. Tessa will be succeeded by Professor Susan Dawson, Dean of the Institute of Veterinary Science at the University of Liverpool and council member of the Royal College of Veterinary Surgeons. Professor Dawson will Chair the Pets Before Profit and Corporate Social Responsibility Committees.
Results presentation
A presentation for analysts and investors will be held today at 10am at Goldman Sachs, River Court, 120 Fleet Street, London EC4A 2BE, attendance is by invitation only. An audio webcast and statement of these results will be available at http://investors.petsathome.com
Investor Relations Enquiries
Pets at Home Group Plc: +44 (0)161 486 6688
Amie Gramlick, Director of Investor Relations
Media Enquiries
Pets at Home Group Plc: +44 (0)161 486 6688
Brian Hudspith, Director of Corporate Affairs
Maitland: +44 (0)20 7379 5151
James McFarlane, Joanna Davidson
About Pets at Home
Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 448 superstores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 461 First Opinion practices located both in our stores and in standalone locations, as well as four Specialist Referral centres. For more information visit: http://investors.petsathome.com/
Disclaimer
This statement of preliminary financial results does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser.
Certain statements in this statement of preliminary financial results constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.
Chief Executive Officer's Review
Operational Highlights
ROLLOUT FY17 FY18 Stores Number of stores(f) 442 448 New superstores (net) 15 13 Vets Number of vet practices (total) 436 461 Number of standalone vet practices 147 152 Number of in-store vet practices 289 309 New vet practices (net) 48 25 Groomers Number of groomers(f) 290 309 New groomers (net) 50 27 % of stores with a vet practice & grooming salon 54% 58% VIP CLUB VIP Club active members (m) (g) 3.7 3.9 VIP swipe as % revenue(h) 68% 70% PRODUCT Proportion of product SKUs refreshed 39% 31%
f FY17 included seven Barkers stores with grooming salons, which have now closed
g Active defined as customers who have purchased during the past twelve months
h Average swipe rate of the card at store tills over latest quarterly period
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Strategic update
Drivers of our like-for-like growth
Home of all things pet
Our biggest competitive asset is the ability to give pet owners the full breadth of pet care; customers who shop across retail, grooming and vet have around three times the spend of those who are just retail customers.
Puppy owners are an opportunity to develop a relationship at one of the most important milestones - the first puppy shop. With that in mind, we gave a complete overhaul to our range and also launched the VIP Puppy Club. By joining the club, customers receive 10% off their first puppy product shop, a free bag of Advanced Nutrition food, their first month for free with a flea product subscription, a free puppy groom and a free vet nurse check. We have seen some great results from our initiative, where we have seen a 25% spending increase by Puppy Club customers.
Home of value and convenience
During the year, we invested cGBP13m in pricing to deliver better value for our customers. We have taken a targeted approach, which began with a campaign that lowered prices and highlighted the value in our private label Advanced Nutrition. This was followed by price adjustments across branded Advanced Nutrition, more food categories and pet essentials. We are confident this is driving a positive reaction with customers, having seen such a strong rebound in Merchandise trade during the year. Advanced Nutrition also performed very well, with 12.7% volume growth and significantly increased private label participation. Looking forward, maintaining a competitive price position will always be part of everyday strategy but this will not be to the same scale as the prior financial year.
Delivering better value for customers is also a priority in our grooming business, where we experienced some slower trading during the year. We are set to launch a trial package in selected salons where for an annual fee, customers can bring their dog for unlimited bath and brush treatments.
Whilst price has been an important part of our improved trading, it doesn't present the full story. Investing in digital helped deliver omnichannel revenue growth of 75%. The two initiatives driving such strong growth are order in-store, and subscription for flea products. We have also improved our website experience with a faster checkout process across mobile, tablet and desktop, and have started to trial repeat order across food products. Looking to the year ahead will see ongoing upgrades to our website look, content and navigation, with more subscription products in our plan.
Home of veterinary excellence
We have a successful veterinary business growing ahead of the market in both First Opinion practices and Specialist Referral Centres. The Vet Group generates cash returns on invested capital(#) of 24% despite the majority of practices (c84%(b) ) being relatively young.
We can attribute the strong revenue growth in our First Opinion practices to a number of competitive differences; but also to the drive of our vet partners in the JV model, who share in the success of the practice. Our model provides vets with business services and cashflow support as they grow, in return for management fees.
The revenue progression for practices, and therefore our fee income, has been relatively consistent. In coming years, as our rollout profile swings more to standalone, rather than in-store practices, we may see some variations in revenue performance, although we still expect the standalone practices to deliver strong returns for the Group.
The path to profit growth for some practices is lengthening as a result of the upward pressure on payroll costs. This factor, combined with the large number of young practices in the business, is leading to increased funding requirements from Pets at Home in the form of working capital operating loans. We expect the overall funding level to continue to grow for the next 4-5 years, after which we expect to see the balance decline, and are comfortable this is mainly a feature of the immaturity of our estate.
With a long term view of growing our practices to maturity, the prize remains; for us in the mature profits from a mainly fixed cost business, and for our vet partners in the form of dividends and the capital value of their practice. We currently have 87 such practices that have fully repaid all debts and we are focusing more on strategies to accelerate growth in our existing practices, to ensure we can deliver the inherent potential of the business.
Retail space evolution and vet practice rollout
With a total of 448 superstores, our store estate is nearing its optimum size. In the coming year we will open only a small number of stores in carefully selected areas, in up to five new locations. At the same time, we will continue to rollout grooming salons amongst the existing store estate and expect to open 10-20.
In our veterinary business we opened a net number of 25 new practices to bring our total to 461. We also transformed more practices to give them extra consulting space, or longer opening hours, so that we have 10 'super surgeries' and six practices opening 24/7. The challenging supply of veterinarians has long been a feature of the UK market and was exacerbated after the Brexit vote (around 30% of vets in the UK are thought to be EU domiciled). In addition, our practice rollout has always been heavily weighted towards the end of our financial year, which has placed an excessive burden on the business and we are taking an active decision to spread this profile more evenly through the year. The supply of veterinarians is unlikely to change in the short term and our priority is to open practices in quality locations for the best vet partners. We expect to open 20-25 practices in the year ahead and have already opened four in the new financial year to date.
Strategic evolution in the year ahead
FY19 will be the second of our three year financial transition back to sustainable profit growth. Delivering the financial plan does not require adhering to our historical strategic priorities of growing like-for-like, space, and margins. Our strategy should evolve with the market and competitive changes, our challenges, and our ambitions.
Our immediate priorities are to address the few remaining areas of our price repositioning programme and taking action to ensure the vet business can deliver on its potential. But in the coming months, we will evolve our longer term strategic plan to become the best pet care business in the world; a bigger focus on digital, data, more services and changing the shape of our stores in an ongoing environment of channel shift.
Peter Pritchard
Group Chief Executive Officer
22 May 2018
Chief Financial Officer's Review
The FY18 audited period represents the 52 weeks to 29 March 2018. The audited comparative period represents 52 weeks to 30 March 2017.
Financial Highlights
FINANCIALS FY17 FY18 Change
Revenue Revenue Split (GBPm)
Food 395.1 421.9 6.8%
Accessories 321.6 343.5 6.8%
Total Merchandise 716.7 765.4 6.8%
Services & other(a) 117.5 133.5 13.7%
Total Group 834.2 898.9 7.8%
Like-For-Like growth(#) 1.5% 5.5%
Merchandise LFL (#) 0.8% 5.0%
Services & other LFL (#) 7.9% 8.5%
Revenue Mix (% of total revenues)
Merchandise 85.9% 85.1% (79) bps
Services & Other 14.1% 14.9% 79 bps
Gross Margin Merchandise Gross Margin 57.6% 54.8% (285) bps
Services & Other Gross Margin 33.3% 34.1% 78 bps
Total Gross Margin 54.2% 51.7% (249) bps
EBITDA Underlying EBITDA(b,) (#) (GBPm) 130.5 123.3 (5.6)%
Underlying EBITDA margin(b,) (#) 15.6% 13.7% (194) bps
Other
Income Statement Underlying PBT (b) (#) (GBPm) 96.4 84.5 (12.3)%
Statutory PBT (GBPm) 95.4 79.6 (16.6)%
Underlying basic EPS(b,) (#) (p) 15.3 13.5 (11.2)%
Statutory basic EPS 15.1 12.6 (16.6)%
Dividend (p) 7.5 7.5 0%
Cashflow & Leverage Free cashflow(#) (GBPm) 64.6 55.8 (13.6)%
CROIC(#) 20.6% 19.4% (89) bps
Leverage (ND/ Underlying EBITDA) (#) 1.2x 1.1x
a. Includes veterinary Joint Venture fees & other veterinary income, specialist referrals revenue, grooming salon revenue, revenue from live pet sales & insurance
b. Non-underlying items in FY18 includes GBP2.7m associated with the closure of Barkers, GBP1.6m accounting charge for the acquisition of minority stakes owned by vet partners in specialist referral centres, and GBP0.6m of other expenses. Non-underlying items in FY17 includes GBP1.0m of expenses for the disposal of Farm Away Limited, the Group's equestrian retailing business.
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Sales and revenue
Group revenue grew by 7.8% to GBP898.9m (FY17: GBP834.2m) and Group like-for-like revenues(#) (LFL) grew 5.5%.
Merchandise revenue, which includes food and accessories, grew by 6.8% to GBP765.4m (FY17: GBP716.7m), with LFL revenue(#) of 5.0%. This reflects particularly strong performance from our omnichannel business, which grew its revenues by 75.1% to GBP51.4m, but also from store sales, which grew by 3.9%. Food revenue grew by 6.8% to GBP421.9m (FY17: GBP395.1m), with strength across all areas of dog and cat food, including Advanced Nutrition, where revenue grew by 6.0% GBP189.8m (FY17: GBP179.1m).
Accessories revenue grew by 6.8% to GBP343.5m (FY17: GBP321.6m), where dog accessories and toys were a core driver, alongside subscription plans in licensed flea prevention products.
Services revenue grew by 13.7% to GBP133.5m (FY17: GBP117.5m), with LFL revenues(#) of 8.5%. We saw good growth across our Vet Group in both Specialist Referral Centres and also the First Opinion business, where practice income increased by 16.1% to GBP53.1m (FY17: GBP45.8m). Also within Services, our grooming salons experienced slower growth than in prior periods, and we also saw some weakness in trade from declining pet sales, which is an ongoing trend.
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Gross margin
Group gross margin declined by 249 bps to 51.7% (FY17: 54.2%).
Gross margin within Merchandise was 54.8%, a reduction of 285 bps over the prior year (FY17: 57.6%), in line with our plans. This mainly reflects our price repositioning activities of cGBP13m, a foreign currency impact of GBP5.7m from the movement in USD versus GBP and the growth of our omnichannel business, which has a greater mix of food product versus higher margin accessories.
Gross margin within Services increased by 78 bps to 34.1% (FY17: 33.3%). We saw expansion in the underlying gross margin of veterinary First Opinion practices and Specialist Referral Centres, but at an overall level, the First Opinion business saw a decline in gross margin due to a GBP5.0m increase in the provision held for practice operating loans. We also experienced a significant improvement in the margin of pet sales in store, which reflects our activities to improve and simplify the care and welfare routines. This benefit is expected to be a one-off feature of FY18.
Underlying EBITDA(#) and operating costs
Underlying EBITDA(#) was GBP123.3m (FY17: GBP130.5m), with a margin of 13.7% (FY17: 15.6%).
Selling and distribution (S&D) expenses of GBP309.5m decreased as a percentage of Group revenue, to 34.4% (FY17: 35.5%). Within this, we saw GBP2.5m in cost savings as a result of our energy saving programme, and occupation costs (rent, service charges and other costs) again declined as a percentage of sales as we benefit from the rent paid by vet practices in our stores, which contributed GBP11.7m (FY17: GBP10.7m). Colleague costs also declined as a percentage of sales, particularly in relation to stores, where we have reduced payroll hours by streamlining non customer facing activities.
Underlying administration expenses of GBP66.3m were 7.4% of revenue (FY17: 6.6%), where we are seeing growth in Vet Group operating costs, alongside our investment in business systems and omnichannel.
Non-underlying costs totaled GBP4.9m. Of this, GBP2.7m relates to the closure of our trial Barkers stores and the associated lease commitments and write down of fixed assets. In addition, GBP1.6m of non-underlying costs were recognised in relation to the ownership structures and accounting treatment of the veterinary Specialist Referral centres (see detailed note below on page 21.) There were also GBP0.6m of M&A related expenses, for transactions that were not completed.
Depreciation and amortisation, which is contained within our total operating costs, increased to GBP34.5m (FY17 GBP29.6m).
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Underlying finance expense
Underlying net finance expense(#) for the year was GBP4.3m (FY17: GBP4.5m).
Taxation, trading profit & EPS
Underlying pre tax profit(#) was GBP84.5m (FY17: GBP96.4m) and statutory pre tax profit, was GBP79.6m (FY17: GBP95.4m).
Underlying total tax expense(#) for the period was GBP17.0m, a rate of 20% on underlying pre tax profit(#) .
Underlying profit for the period(#) , after tax, was GBP67.5m (FY17: GBP76.3m) and underlying basic earnings per share(#) were 13.5 pence, (FY17: 15.3 pence). Statutory basic earnings per share were 12.6 pence (FY17: 15.1 pence).
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Working capital(#) and funding for vet practices
The cash movement in trading working capital(#) for FY18 was an inflow of GBP9.4m. This was comprised of a GBP4.1m increase in inventory, offset by a GBP3.9m decrease in receivables and a GBP9.6m increase in payables.
We increased our working capital support to First Opinion veterinary practices with GBP14.8m in operating loans. This created an overall increase in Group receivables of GBP10.9m and overall Group cash working capital outflow of GBP5.4m.
Operating loans represent cash funding we choose to provide to Joint Venture First Opinion veterinary practices, to assist with their working capital requirements and underpin their growth to maturity. The gross value of operating loans at the end of the financial year was GBP38.0m (FY17: GBP23.2m), against which a provision of GBP8.3m is held (FY17: GBP3.3m). The increased provision reflects both the longer maturity curves for practices, as well as an improvement in methodology used to assess the operating loan balance. A provision has been applied to all outstanding practice loan balances, which we believe is more appropriate considering the growing size of our First Opinion business.
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Capital investment
Capital investment was GBP40.7m (FY17: GBP44.5m), where GBP12.8m is represented by the refurbishment and retrofit of services into our existing store estate (FY17 GBP16.8m) and new store capital investment totalled GBP7.3m (FY17: GBP6.4m). Investment in business systems totalled GBP10.0m (FY17: GBP7.2m), and GBP2.3m was part of the energy savings programme to fit LED lighting and smart energy management systems in our store estate (FY17: GBP5.8m). Cash capital expenditure was GBP41.6m (FY17: GBP40.9m).
Cashflow and capital structure
Free cash flow (FCF) after interest, tax and before acquisitions(#) was GBP55.8m (FY17: GBP64.6m), representing a cash conversion rate of 45% (FY17: 49%). The decline in FCF when compared with the prior year is driven by our price investments in the Merchandise business, increased working capital requirements and the purchase of shares to satisfy colleague stock option schemes.
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Free cashflow (#) (GBPm) FY17 FY18 Cash EBITDA(c,#) 133.0 127.2 Working capital(#) (2.4) (5.4) Operating loans provision movement 0.1 5.0 Tax (19.3) (19.1) Interest cost (4.2) (3.9) Capital expenditure (42.6) (44.0) Purchase of shares for colleague stock options 0.0 (4.0) Reported free cashflow 64.6 55.8
c. Defined as underlying EBITDA plus IFRS2 share based payment charges
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
The Group's net debt position at the end of period was GBP135.2m, which represents a leverage ratio(#) of 1.1x underlying EBITDA.
GBPm FY17 FY18
(53 (53
Opening net debt (162.0) 153.7
Free cashflow(#) 64.6 55.8
Ordinary dividends paid (39.9) (37.3)
Acquisitions (14.8) 0.0
Other (1.6) 0.0
--------------------------------------- -------- --------
Closing net debt (153.7) (135.2)
Leverage (ND / underlying EBITDA(#) ) 1.2x 1.1x
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Our capital structure and allocation policy remains as previously stated, with a priority to invest in areas that will expand the Group and deliver appropriate returns, particularly within our veterinary business. It is our intention to maintain a prudent approach to balance sheet management in the current economic environment, but retain some flexibility to increase leverage to an appropriate level in the event that suitable investment or acquisition opportunities arise. And dependent upon our acquisition outlook and if we do not foresee investment uses, it is our intention to return surplus free cashflow to shareholders.
Dividend
The Board has recommended a final dividend of 5.0 pence per share, giving a total dividend of 7.5 pence per share in respect of the 2018 financial year, equal with the prior year.
The final dividend will be proposed by the Directors at the 2018 AGM and is in addition to the interim dividend of 2.5 pence per share, paid to shareholders on the 12 January 2018. The ex-dividend date will be 14 June 2018 and, if approved at the Company's forthcoming AGM, will be paid to shareholders on 17 July 2018 to those shareholders on the register at the close of business on 15 June 2018.
Foreign exchange outlook
The Group purchases products from Asia to a value of around US$65 million each year. Our policy is to use a mix of foreign exchange forward contracts to hedge our USD requirement for the next 12 months and up to 50% of the following 6 months. The movement in hedged contract rates for FY18, which were at an average rate of 1.30 USD:GBP, created a GBP5.7m adverse cost to the Group. The majority of our hedging requirement for FY19 is in place, at an average rate of 1.34 USD:GBP, which is expected to have a positive financial impact of around cGBP1 million.
Accounting treatment of veterinary Specialist Referral centres
Three of our four centres are structured as a Shared Venture ownership model, where Pets at Home maintains a minimum 75% controlling share, with the remaining shares owned by multiple clinician Shared Venture Partners (SVPs). Pets at Home has an option to buy the SVP shares in the future, with the value of these shares related to profit performance targets. The accounting treatment of such an option is therefore structured as a forward contract. Within the income statement, the discounted future value of the SVP's shares is recognised as an expense over the period to which the option can be exercised, and recognised as an non-underlying expense. We continue to expect this charge to be GBP1.5-2m for FY19.
New financial reporting disclosure
In FY19 our financial reporting will change to two segments that better represent the size of the respective businesses and our internal reporting structures; Retail (includes products purchased online and in-store, pet sales and grooming services) and Vet Group (includes our First Opinion practices both in-store and online, and Specialist Referral veterinary centres).
In order to familiarise readers of the accounts, and provide a basis for comparability, we show a proforma unaudited segmentation for the 52 weeks to 29 March 2018.
GBPm Retail Vet Group Central costs Total Group LFL revenue growth (#) 4.6% 15.0% 5.5% Revenue 804.9 94.1 898.9 Gross margin 52.2% 47.1% 51.7% Underlying EBITDA(#) 97.3 (d) 31.9 (e) (5.8) 123.3 (3) Underlying EBIT(#) 65.1 (d) 29.6 (e) (5.8) 88.8 (3)
d. Non-underlying items: GBP2.7m associated with the closure of Barkers
e. Non-underlying items: GBP1.6m accounting charge for the acquisition of minority stakes owned by vet partners in specialist referral centres, and GBP0.6m of other expenses
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Mike Iddon
Chief Financial Officer
22 May 2018
Alternative Performance Measures ("APMs")
Guidelines on Alternative Performance Measures (APMs) issued by the European Securities and Markets Authority came into effect for all communications released on or after 3 July 2016 for issuers of securities on a regulated market.
In the reporting of financial information, the Directors have adopted various APMs of historical or future financial performance, position or cash flows other than those defined or specified under International Financial Reporting Standards (IFRS).
The Directors measure the performance of the Group based on the following financial measures which are not recognised under EU-adopted IFRS, and consider these to be important measures in evaluating the Group's strategic and financial performance. The Directors believe that these APMs assist in providing additional useful information on the underlying trends, performance and position of the Group.
APMs are also used to enhance the comparability of information between reporting periods, by adjusting for non-underlying items, to aid the user in understanding the Group's performance.
Consequently, APMs are used by the Directors and management for performance analysis, planning, reporting and incentive setting purposes and have remained consistent with prior year.
All APMs relate to the current period's results and comparative periods where provided.
The key APMs used by the Group are:
'Like-for-Like' sales growth comprises total revenue in a financial period compared to revenue achieved in a prior period, for stores, online operations, grooming salons, vet practices & Specialist Referral centres that have been trading for 52 weeks or more
Omnichannel revenue: revenue net of discounts and VAT from core online, sales, subscriptions and order to store.
EBITDA: Earnings before interest, tax, depreciation and amortisation before the effect of non-underlying items in the period.
Free Cash Flow: being net cash from operating activities, after tax, less net cash used in investing activities (excluding acquisitions), less interest paid and debt issue costs, and is stated before cash flows for non-underlying costs.
CROIC: Cash return on invested capital, represents cash returns divided by the average of gross capital (GCI) invested for the last twelve months. Cash returns represent pre-Non-underlying operating profit before property rentals and share based payments subject to tax then adjusted for depreciation and amortisation. GCI represents gross property, plant and equipment plus software and other intangibles excluding the goodwill created on the acquisition of the Group by KKR (GBP906,445,000) plus net working capital, plus capitalised rent multiplied by a factor of 8x.
Financial Statements
Financial Information
The financial information set out in this preliminary statement of annual results has been extracted from the Group's financial statements, which have been approved by a resolution of the Board of directors of the Company on 22 May 2018 and agreed with the Company's auditor.
The financial information set out in this preliminary statement does not constitute the Company's statutory accounts for the year ended 29 March 2018 as defined in section 434 of the Companies Act 2006 (the "Act") which have not yet been delivered to the Registrar of Companies.
The Company's auditor has reported on the FY18 financial statements. Its reports were unqualified and did not draw attention to any matters by way of emphasis. The reports also did not contain statements under section 498 of the Act.
Consolidated income statement
52 week period ended 52 week period ended 30 March
29 March 2018 2017
------------------------ ------ ----------------------------------------- -----------------------------------------
Non-underlying
Underlying Non-underlying Underlying items (note
trading items (note Total trading 3) Total
Note GBP000 3) GBP000 GBP000 GBP000 GBP000 GBP000
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
Revenue 2 898,924 - 898,924 834,169 - 834,169
Cost of sales (434,316) - (434,316) (382,287) - (382,287)
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
Gross profit 464,608 - 464,608 451,882 - 451,882
Selling and distribution
expenses (309,482) - (309,482) (296,012) - (296,012)
Administrative expenses 3 (66,323) (4,929) (71,252) (54,950) (996) (55,946)
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
Operating profit 2,3 88,803 (4,929) 83,874 100,920 (996) 99,924
Financial income 6 685 - 685 760 - 760
Financial expense 7 (4,963) - (4,963) (5,300) - (5,300)
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
Net financing expense (4,278) - (4,278) (4,540) - (4,540)
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
Profit before tax 84,525 (4,929) 79,596 96,380 (996) 95,384
Taxation 8 (16,983) 201 (16,782) (20,061) 41 (20,020)
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
Profit for the period 67,542 (4,728) 62,814 76,319 (955) 75,364
------------------------ ------ ------------ ---------------- --------- ------------ ---------------- ---------
All activities relate to continuing operations.
Basic and diluted earnings per share attributable to equity shareholders of the Company:
52 week 52 week
period ended period ended
29 March 30 March
Note 2018 2017
-------------------------------------- ------ --------------- ---------------
Equity holders of the parent - basic 5 12.6p 15.1p
Equity holders of the parent- diluted 5 12.5p 15.0p
-------------------------------------- ------ --------------- ---------------
Dividends paid and proposed are disclosed in note 9.
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Consolidated statement of comprehensive income
52 week
period ended 52 week period
29 March ended 30
2018 March 2017
Note GBP000 GBP000
-------------------------------------------------- ------- --------------- ----------------
Profit for the period 62,814 75,364
Other comprehensive income
Items that are or may be recycled subsequently
into profit or loss:
Foreign exchange translation differences 71 (26)
Cash flow hedges - reclassified to profit and
loss (473) (330)
Effective portion of changes in fair value of
cash flow hedges (1,695) 1,862
----------------------------------------------------------- --------------- ----------------
Other comprehensive income for the period, before
income tax (2,097) 1,506
Income tax on other comprehensive income 412 (297)
----------------------------------------------------------- --------------- ----------------
Other comprehensive income for the period, net
of income tax (1,685) 1,209
----------------------------------------------------------- --------------- ----------------
Total comprehensive income for the period 61,129 76,573
----------------------------------------------------------- --------------- ----------------
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Consolidated balance sheet
At 29 March At 30 March
Note 2018 GBP000 2017 GBP000
--------------------------------------------- ------ -------------- --------------
Non-current assets
Property, plant and equipment 129,904 128,835
Intangible assets 992,929 990,266
Other non-current assets 20,182 16,990
--------------------------------------------- ------ -------------- --------------
1,143,015 1,136,091
--------------------------------------------- ------ -------------- --------------
Current assets
Inventories 60,529 56,420
Other financial assets 1,160 1,863
Trade and other receivables 74,848 69,567
Cash and cash equivalents 59,824 56,345
--------------------------------------------- ------ -------------- --------------
196,361 184,195
--------------------------------------------- ------ -------------- --------------
Total assets 1,339,376 1,320,286
--------------------------------------------- ------ -------------- --------------
Current liabilities
Trade and other payables (173,856) (165,887)
Corporation tax (8,881) (10,609)
Provisions (835) (492)
Other financial liabilities (3,392) (1,509)
--------------------------------------------- ------ -------------- --------------
(186,964) (178,497)
--------------------------------------------- ------ -------------- --------------
Non-current liabilities
Other interest-bearing loans and borrowings 10 (194,519) (209,296)
Other payables (36,200) (35,028)
Provisions (2,200) (1,394)
Other financial liabilities (8,693) (8,023)
Deferred tax liabilities (4,448) (5,404)
--------------------------------------------- ------ -------------- --------------
(246,060) (259,145)
--------------------------------------------- ------ -------------- --------------
Total liabilities (433,024) (437,642)
--------------------------------------------- ------ -------------- --------------
Net assets 906,352 882,644
--------------------------------------------- ------ -------------- --------------
Equity attributable to equity holders of the
parent
Ordinary share capital 5,000 5,000
Consolidation reserve (372,026) (372,026)
Merger reserve 113,321 113,321
Translation reserve 40 (31)
Cash flow hedging reserve (950) 806
Retained earnings 1,160,967 1,135,574
--------------------------------------------- ------ -------------- -------------- Total equity 906,352 882,644 --------------------------------------------- ------ -------------- --------------
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
On behalf of the Board:
Mike Iddon Group Chief Financial Officer
Company number: 08885072
Consolidated statement of changes in equity as at 29 March 2018
Cash flow
Share Consolidation Merger hedging Translation Retained Total
capital reserve reserve reserve reserve earnings equity
GBP000 GBP000 GBP000 GBP000 GBP000 GBP000 GBP000
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Balance at 30 March 2017 5,000 (372,026) 113,321 806 (31) 1,135,574 882,644
Total comprehensive
income
for the period
Profit for the period - - - - 62,814 62,814
Other comprehensive
income - - - (1,756) 71 - (1,685)
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Total comprehensive
income
for the period - - - (1,756) 71 62,814 61,129
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Transactions with owners,
recorded directly in
equity
Equity dividends paid - - - - - (37,341) (37,341)
Share based payment
charge 3,936 3,936
Purchase of own shares - - - - - (4,016) (4,016)
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Total contributions by
and
distributions to owners - - - - - (37,421) (37,421)
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Balance at 29 March 2018 5,000 (372,026) 113,321 (950) 40 1,160,967 906,352
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Consolidated statement of changes in equity as at 30 March 2017
Cash flow
Share Consolidation Merger hedging Translation Retained Total
capital reserve reserve reserve reserve earnings equity
GBP000 GBP000 GBP000 GBP000 GBP000 GBP000 GBP000
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Balance at 31 March 2016 5,000 (372,026) 113,321 (429) (5) 1,097,623 843,484
Total comprehensive
income
for the period
Profit for the period - - - - 75,364 75,364
Other comprehensive
income - - - 1,235 (26) - 1,209
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Total comprehensive
income
for the period - - - 1,235 (26) 75,364 76,573
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Transactions with owners,
recorded directly in
equity
Equity dividends paid - - - - - (39,850) (39,850)
Share based payment
charge - - - - - 2,437 2,437
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Total contributions by
and
distributions to owners - - - - - (37,413) (37,413)
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
Balance at 30 March 2017 5,000 (372,026) 113,321 806 (31) 1,135,574 882,644
------------------------- ---------- --------------- ---------- ----------- ------------- ----------- ---------
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Consolidated statement of cash flows
52 week period 52 week period
ended ended
29 March 30 March
2018 2017
GBP000 GBP000
--------------------------------------------------------- ---------------- ----------------
Cash flows from operating activities
Profit for the period 62,814 75,364
Adjustments for:
Depreciation and amortisation 34,483 29,621
Financial income (685) (760)
Financial expense 4,963 5,300
Loss on disposal of subsidiary - 690
Loss/(profit) on disposal of property, plant & equipment 1,628 (176)
Share based payment charges 3,936 2,437
Taxation 16,782 20,020
--------------------------------------------------------- ---------------- ----------------
123,921 132,496
Increase in trade and other receivables (5,234) (8,863)
Increase in inventories (4,531) (4,979)
Increase in trade and other payables 11,474 11,469
Increase in provisions 1,149 63
--------------------------------------------------------- ---------------- ----------------
126,779 130,186
Tax paid (19,054) (19,299)
--------------------------------------------------------- ---------------- ----------------
Net cash flow from operating activities 107,725 110,887
--------------------------------------------------------- ---------------- ----------------
Cash flows from investing activities
Proceeds from sale of property, plant and equipment 814 1,830
Disposal of subsidiary, net of cash disposed - 677
Interest received 685 722
Investment in other financial assets (2,146) (3,420)
Loans issued (872) (2,247)
Loans repaid - 500
Acquisition of subsidiary, net of cash acquired - (14,831)
Acquisition of property, plant and equipment and other
intangible assets (41,613) (40,896)
--------------------------------------------------------- ---------------- ----------------
Net cash used in investing activities (43,132) (57,665)
--------------------------------------------------------- ---------------- ----------------
Cash flows from financing activities
Equity dividends paid (37,341) (39,850)
Proceeds from new loan - 8,000
Repayment of borrowings (15,000) -
Purchase of own shares (4,016) -
Finance lease obligations (181) (109)
Interest paid (4,576) (4,916)
--------------------------------------------------------- ---------------- ----------------
Net cash used in financing activities (61,114) (36,875)
--------------------------------------------------------- ---------------- ----------------
Net Increase in cash and cash equivalents 3,479 16,347 Cash and cash equivalents at beginning of period 56,345 39,998 --------------------------------------------------------- ---------------- ---------------- Cash and cash equivalents at end of period 59,824 56,345 --------------------------------------------------------- ---------------- ----------------
# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible
Notes
1 Basis of preparation
Pets at Home Group Plc (the Company) is a company incorporated in the United Kingdom and its registered office is Epsom Avenue, Stanley Green, Handforth, Cheshire, SK9 3RN.
The company is listed on the London Stock Exchange.
The consolidated financial statements for the 52 week period ended 29 March 2018 have been prepared in accordance with International Financial Reporting Standards as adopted by the EU (Adopted IFRS) and were approved by the Directors of the Company on 21(st) May 2018 along with this preliminary announcement.
The consolidated financial statements are prepared on the historical costs basis except for derivative financial instruments, share based payments and certain investments measured at their fair value.
The financial information included in this preliminary statement of results does not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006 (the "Act"). The financial information for the 52 week period ended 29 March 2018 has been extracted from the statutory accounts on which an unqualified audit
opinion has been issued. Statutory accounts for the 52 week period ended 29 March 2018 will be delivered to the Registrar of Companies following the Company's Annual General Meeting.
The auditors have consented to the publication of the Preliminary Announcement as required by Listing Rule 9.7a having completed their procedures under APB bulletin 2008/2.
The directors of Pets at Home Group Plc, having made appropriate enquiries, consider that adequate resources exist for the Group to continue in operational existence for the foreseeable future and that, therefore, it is appropriate to adopt the going concern basis in preparing the consolidated financial statements for the 52 week period ended 29 March 2018.
2 Segmental reporting
The Directors consider there to be one operating and reportable segment, being that of the sale of pet products and services through retail outlets, specialist vet referral services and the Group's websites.
The Group's Board receives monthly financial information at this level and uses this information to monitor the performance of the store portfolio, allocate resources and make operational decisions. The internal reporting received focuses on the Group as a whole and does not identify other individual segments. To increase transparency, the Group has decided to include an additional voluntary disclosure analysing revenue within the reportable segment.
52 week 52 week
period period
ended 29 ended 30
March 2018 March 2017
Revenue GBP000 GBP000
------------------- ----------- -----------
Food 421,894 395,121
Accessories 343,508 321,550
Services and other 133,522 117,498
------------------- ----------- -----------
898,924 834,169
------------------- ----------- -----------
The 'services and other' category includes revenue from management fees for first opinion veterinary surgeries, veterinary services, grooming services, insurance commissions and the sale of pets.
The performance of the operating segment is primarily based on a measure of earnings before interest, tax, depreciation, and amortisation (EBITDA) before Non-underlying items. This can be reconciled to statutory operating profit as follows:
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
-------------------------------------------------------- -------------- --------------
Operating profit 83,874 99,924
Non-underlying items 4,929 996
-------------------------------------------------------- -------------- --------------
Underlying operating profit before Non-underlying items 88,803 100,920
-------------------------------------------------------- -------------- --------------
Depreciation and amortisation 34,483 29,621
-------------------------------------------------------- -------------- --------------
Underlying EBITDA 123,286 130,541
-------------------------------------------------------- -------------- --------------
3 Expenses and auditor's remuneration
Included in operating profit are the following:
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
---------------------------------------------- -------------- --------------
Non-underlying operating expenses (see below) 4,929 996
Depreciation of tangible fixed assets 28,280 25,690
Amortisation of intangible assets 6,203 3,931
Rentals under operating leases:
Hire of plant and machinery 4,387 4,484
Property 75,922 73,002
Rental income from third party sublets (1,041) (828)
Rental income from related parties (7,138) (6,277)
Profit on disposal of fixed assets - (176)
Share based payment charges 3,936 2,437
---------------------------------------------- -------------- --------------
Non-underlying items in operating profit in the 52 week period ended 29 March 2018 totalled GBP4,929,000 (2017: GBP996,000). Of this, GBP2,685,000 relates to the closure of our seven trial Barkers stores, the associated lease commitments including disposal of fixed assets (GBP1,628,000). Non-underlying operating expenses also includes GBP1,625,000 in relation to the increase in the fair value of the put and call option over the non-controlling interests in Dick White Referrals Limited, Eye-Vet Limited and Anderson Moores Veterinary Specialists Limited and GBP619,000 in relation to aborted property and acquisition costs.
Non-underlying items in operating profit in the period ended 30 March 2017 of GBP966,000 represent costs incurred in relation to the disposal of the Groups 100% holding in Farm-Away Ltd. The costs include legal and professional fees, redundancy costs and property costs.
The costs noted above are considered by the Directors to be non-underlying as they relate to either an event that is not expected to re-occur in future periods (as is the case with the closure of Barkers and disposal of Farm-Away), or the increase in the fair value of put/call liabilities which the Directors consider warrant separate disclosure due to the nature of these arrangements.
4 Colleague numbers and costs
The average number of persons employed (full time equivalents) by the Group (including Directors) during the period, analysed by category, was as follows:
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
Number Number
----------------------- -------------- --------------
Sales and distribution 6,142 6,152
Administration 559 659
----------------------- -------------- --------------
6,701 6,811
----------------------- -------------- --------------
The aggregate payroll costs of these persons were as follows:
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
---------------------------------------------------- -------------- --------------
Wages and salaries 180,952 162,936
Social security costs 15,233 13,337
Contributions to defined pension contribution plans 5,725 5,251
---------------------------------------------------- -------------- --------------
201,910 181,524
---------------------------------------------------- -------------- --------------
5 Earnings per share
Basic earnings per share is calculated by dividing the net profit for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
Diluted earnings per share is calculated by dividing the net profit for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on the conversion of all dilutive potential ordinary shares into ordinary shares.
52 week period ended 52 week period ended
29 March 2018 30 March 2017
------------------------------------------- --------------------------------- ---------------------------------
Underlying After Non-underlying Underlying After Non-underlying
trading items trading items
------------------------------------------- ----------- -------------------- ----------- --------------------
Profit attributable to equity shareholders
of the parent (GBP000s) 67,542 62,814 76,319 75,364
------------------------------------------- ----------- -------------------- ----------- --------------------
Basic weighted average number of shares 500,000,000 500,000,000 500,000,000 500,000,000
Dilutive potential ordinary shares 3,119,537 3,119,537 4,032,406 4,032,406
------------------------------------------- ----------- -------------------- ----------- --------------------
Diluted weighted average number of shares 503,119,537 503,119,537 504,032,406 504,032,406
------------------------------------------- ----------- -------------------- ----------- --------------------
Basic earnings per share 13.5p 12.6p 15.3p 15.1p
Diluted earnings per share 13.4p 12.5p 15.1p 15.0p
------------------------------------------- ----------- -------------------- ----------- --------------------
6 Finance income
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
--------------------- -------------- --------------
Interest receivable 685 760
Total finance income 685 760
--------------------- -------------- --------------
7 Finance expense
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
-------------------------------------- -------------- --------------
Bank loans at effective interest rate 4,773 5,113
Other interest expense 190 187
-------------------------------------- -------------- --------------
Total finance expense 4,963 5,300
-------------------------------------- -------------- --------------
8 Taxation
Recognised in the income statement
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
------------------------------------------------------ -------------- --------------
Current tax expense
Current period 17,837 20,953
Adjustments in respect of prior periods (511) (964)
------------------------------------------------------ -------------- --------------
Current tax expense 17,326 19,989
------------------------------------------------------ -------------- --------------
Deferred tax expense
Origination and reversal of temporary differences (669) (907)
Impact of difference between deferred and current tax
rates (260) 45
Adjustments in respect of prior periods 385 893
------------------------------------------------------ -------------- --------------
Deferred tax expense (544) 31
------------------------------------------------------ -------------- --------------
Total tax expense 16,782 20,020
------------------------------------------------------ -------------- --------------
The UK corporation tax standard rate for the period was 19% (2017: 20%). The March 2016 budget announced a further reduction in the corporation tax rate to 17% from 1 April 2020. The deferred tax liability has been calculated based on the rate of 18% which is the blended rate at which items are expected to reverse.
Deferred tax recognised in comprehensive income
52 week period 52 week period
ended 29 ended 30
March 2018 March 2017
GBP000 GBP000
-------------------------------------------------------- -------------- --------------
Effective portion of changes in fair value of cash flow
hedges (412) 297
-------------------------------------------------------- -------------- --------------
Reconciliation of effective tax rate
52 week period ended 29 52 week period ended 30 March
March 2018 2017
----------------------------------- ----------------------------------------
Underlying
trading Non-underlying Total Underlying Non-underlying Total
GBP000 items GBP000 GBP000 trading GBP000 items GBP000 GBP000
-------------------------------- ---------- -------------- ------- --------------- -------------- -------
Profit for the period 67,542 (4,728) 62,814 76,319 (955) 75,364
Total tax expense 16,983 (201) 16,782 20,061 (41) 20,020
-------------------------------- ---------- -------------- ------- --------------- -------------- -------
Profit excluding taxation 84,525 (4,929) 79,596 96,380 (996) 95,384
-------------------------------- ---------- -------------- ------- --------------- -------------- -------
Tax using the UK corporation
tax rate for the period of
20% (53 week period ended 31
March 2016: 20%) 16,060 (937) 15,123 19,276 (199) 19,077
Impact of change in tax rate
on deferred tax balances (260) - (260) 45 - 45
Depreciation on expenditure
not eligible for tax relief 588 - 588 706 - 706
Expenditure not eligible for
tax relief 721 736 1,457 105 158 263
Adjustments in respect of prior
periods (126) - (126) (71) - (71)
-------------------------------- ---------- -------------- ------- --------------- -------------- -------
Total tax expense 16,983 (201) 16,782 20,061 (41) 20,020
-------------------------------- ---------- -------------- ------- --------------- -------------- -------
The UK corporation tax standard rate for the 52 week period ended 29 March 2018 was 19% (52 week period ended 30 March 2017: 20%). The effective tax rate before Non-underlying items for the 52 week period ended 31 March 2018 was 20%. The principal reason for the difference in rate relates to the non-deductibility of depreciation charged on certain items of capital expenditure.
9 Dividends paid and proposed
52 week period 52 week period
ended ended
29 March 30 March
2018 2017
GBP000 GBP000
---------------------------------------------------------- -------------- --------------
Declared and paid during the period
Final dividend of 5.5p per share (2017: 5.5p per share) 24,912 27,396
Interim dividend of 2.5p per share (2017: 2.5p per share) 12,429 12,454
---------------------------------------------------------- -------------- --------------
Proposed for approval by shareholders at the AGM
Final dividend of 5.0p per share (2017: 5.0p per share) 24,836 24,912
---------------------------------------------------------- -------------- --------------
The trustees of the following holdings of Pets at Home Group Plc shares under the Pets at Home Group Employee Benefit Trusts have waived or otherwise foregone any and all dividends paid in relation to the period ended 29 March 2018 and 30 March 2017 and to be paid at any time in the future (subject to the exceptions in the relevant trust deed) on its respective shares for the time being comprised in the Trust Funds: Computershare Nominees (Channel Islands) Limited (holding at 29 March 2018: 3,271,102 shares, holding at 30 March 2017: 1,319,091 shares) and Wealth Nominees Limited (holding at 29 March 2018: nil shares, holding at 30 March 2017: 434,056 shares).
10 Other interest-bearing loans and borrowings
At 29 March At 30 March
2018 GBP000 2017 GBP000
------------------------ ------------ ------------
Non-current liabilities
Secured bank loans 194,519 209,296
Total liabilities
------------------------ ------------ ------------
Secured bank loans 194,519 209,296
------------------------ ------------ ------------
Terms and debt repayment schedule
Carrying Carrying
Face value amount at Face value amount at
Nominal at 29 March 29 March at 30 March 30 March
interest 2018 2018 2017 2017
Currency rate Year of maturity GBP000 GBP000 GBP000 GBP000
-------------------- --------- ------------- ---------------- ------------ ---------- ------------ ----------
Senior Finance Bank
Loans GBP LIBOR +1.25% 2020 195,000 194,519 210,000 209,296
-------------------- --------- ------------- ---------------- ------------ ---------- ------------ ----------
The Group's Senior Financing Facilities (as amended in April 2015) include a revolving credit facility (RCF) of GBP260m. The RCF expires in April 2020 and is reviewed each period. Interest is charged at LIBOR plus a margin based on leverage (net debt: EBITDA). Face value represents the principal value of the Senior Finance Bank Loans. The bank loan is secured against the various tangible, intangible and monetary assets of the Group (excluding investments in joint ventures and hedging agreements).
Interest-bearing borrowings are recognised initially at fair value, being the principal value of the loan net of attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at a carrying value, which represents the amortised cost of the loans using the effective interest method less any impairment losses.
At 29 March 2018 the Group had a revolving credit facility of GBP260m with a drawn amount of GBP195m.
The analysis of repayments on the loans is as follows:
At 30 March
At 29 March 2017
2018 GBP000 GBP000
--------------------------------------- ------------ -----------
Within one year or repayable on demand - -
Between one and two years - -
Between two and five years 195,000 210,000
--------------------------------------- ------------ -----------
195,000 210,000
--------------------------------------- ------------ -----------
The combined loans at 29 March 2018 and 30 March 2017 are held by the Company.
Analysis of changes in net debt
At Non-cash At
30 March Cash flow movement 29 March
2017 GBP000 GBP000 GBP000 2018 GBP000
--------------------------------------- ------------ --------- --------- ------------
Cash and cash equivalents 56,345 3,479 - 59,824
Debt due within one year at face value - - - -
Debt due after one year at face value (210,000) 15,000 - (195,000)
--------------------------------------- ------------ --------- --------- ------------
Net debt (153,655) 18,479 - (135,176)
--------------------------------------- ------------ --------- --------- ------------
Glossary - Alternative Performance Measures
Guidelines on Alternative Performance Measures (APMs) issued by the European Securities and Markets Authority came into effect for all communications released on or after 3 July 2016 for issuers of securities on a regulated market.
In the reporting of financial information, the Directors have adopted various APMs of historical or future financial performance, position or cash flows other than those defined or specified under International Financial Reporting Standards (IFRS).
The Directors measure the performance of the Group based on the following financial measures which are not recognised under EU-adopted IFRS, and consider these to be important measures in evaluating the Group's strategic and financial performance. The Directors believe that these APMs assist in providing additional useful information on the underlying trends, performance and position of the Group.
APMs are also used to enhance the comparability of information between reporting periods, by adjusting for non-underlying items, to aid the user in understanding the Group's performance.
Consequently, APMs are used by the Directors and management for performance analysis, planning, reporting and incentive setting purposes and have remained consistent with prior year.
All APMs relate to the current period's results and comparative periods where provided.
APM Definition Reconciliation
-----------------------------
Cash Underlying EBITDA Cash EBITDA FY17 FY18 Note
EBITDA (see below) adjusted (GBPm)
for share based payment
charge.
--------------- -----------------------------
Underlying
EBITDA 130.5 123.3
Share based
payment
charge 2.4 3.9 3
--------- --------- ------------
Cash EBITDA 132.9 127.2
-------------------------------------------------------------------------- --------- --------- ------------
CROIC Cash return on invested CROIC FY17 FY18 Note
capital, represents
cash returns divided
by the average of
gross capital (GCI)
invested for the last
twelve months. Cash
returns represent
underlying operating
profit before property
rentals and share
based payments subject
to tax then adjusted
for depreciation and
amortisation. GCI
represents gross property,
plant and equipment
plus software and
other intangibles
excluding the goodwill
created on the acquisition
of the Group by KKR
(GBP906,445,000) plus
net working capital,
plus capitalised rent
multiplied by a factor
of 8x.
--------------- -----------------------------
Cash returns:
--------------- -----------------------------
Underlying
operating
profit 100.9 88.8
Property
rental costs 73 75.9 3
Share based
payment
charges 2.4 3.9 3
--------- --------- ------------
176.4 168.7
Effective
tax rate 20% 20%
Tax charge
on above -35.3 -33.7
--------- --------- ------------
141.1 134.9
Depreciation
and amortisation 29.6 34.5 3
--------- --------- ------------
Cash returns 170.7 169.4
Gross capital
invested
(GCI):
Gross property,
plant and
equipment 234.9 263.1
Intangibles 1,005.50 1,014.40
Less KKR
goodwill -906.5 -906.5
Investments 12.6 14.7
Net working see
capital -87.4 -89.8 definition
Capitalised
operating
leases 584 607.4 8x
--------- --------- ------------
GCI 843.1 903.3
Average 827.6 873.2
--------- --------- ------------
Cash returns/average
CGI 20.60% 19.40%
-------------------------------------------------------------------------- --------- --------- ------------
Underlying Earnings before interest, Underlying FY17 FY18 Note
EBITDA tax, depreciation EBITDA (GBPm)
and amortisation before
the effect of Non-underlying
items in the period.
This is a key management
incentive metric.
--------------- -----------------------------
Statutory
operating
profit (audited) 99.9 83.9
Depreciation
and amortisation -29.6 -34.5 3
Non-underlying
items -1 -4.9 3
--------- --------- ------------
Underlying
EBITDA 130.5 123.3
-------------------------------------------------------------------------- --------- --------- ------------
Free Free cash flow being Free cash FY17 FY18 Note
cash net cash from operating flow (GBPm)
flow activities, after
tax, less net cash
used in investing
activities (excluding
acquisitions), less
interest paid, debt
issue costs, purchase
of own shares and
finance lease obligations,
and is stated before
cash flows for
Non-underlying
costs.
--------------- -----------------------------
Free cash
flow 64.6 55.8
Dividends -39.9 -37.3 CFS
Acquisition -14.8 - CFS
of subsidiary
Disposal 0.7 - CFS
of subsidiary
Loans issued -2.2 - CFS
Proceeds 8 - CFS
from new
loan
Repayment - -15 CFS
of borrowings
--------- --------- ------------
Net increase
in cash 16.3 3.5
CFS = Consolidated Statement
of Cash Flows
--------------- ----------------------------- ----------------------------------------------------------
Gross Gross profit divided Information provided in
profit by revenue expressed the consolidated income
margin as a percentage statement.
(%)
--------------- ----------------------------- ----------------------------------------------------------
Like-for-like 'Like-for-like' sales Not applicable.
growth comprises total
revenue in a financial
period compared to
revenue achieved in
a prior period, for
stores, online operations,
grooming salons, vet
practices and referral
centres that have
been trading for 52
weeks or more
--------------- ----------------------------- ----------------------------------------------------------
Net debt Cash and cash equivalents A reconciliation of net
less loans and borrowings debt is provided in note
10.
--------------- ----------------------------- ----------------------------------------------------------
Underlying Underlying basic earnings Underlying FY17 FY18 Note
basic per share (EPS) is basic EPS
EPS based on earnings (p)
per share before the
impact of certain
costs or incomes that
derive from events
or transactions that
fall outside the normal
activities of the
Group, and are excluded
by virtue of their
size and nature in
order to reflect
management's
view of the performance
of the Group.
--------------- -----------------------------
Underlying
basic EPS 15.3 13.5
Non-underlying
items -0.2 -0.9 5
-------- ---------- ------------
Basic Earnings
per share 15.1 12.6
-------------------------------------------------------------------------- -------- ---------- ------------
Underlying Underlying operating Underlying FY17 FY18 Note
operating profit is based on operating
profit operating profit before profit (GBPm)
the impact of certain
costs or incomes that
derive from events
or transactions that
fall outside the normal
activities of the
Group, and are excluded
by virtue of their
size and nature in
order to reflect
management's
view of the performance
of the Group.
--------------- -----------------------------
Underlying
operating
profit 100.9 88.8
Non-underlying
items -1 -4.9 3
-------- ---------- ------------
Operating
profit 99.9 83.9
-------------------------------------------------------------------------- -------- ---------- ------------
Underlying Underlying profit Underlying FY17 FY18 Note
profit before tax (PBT) is PBT (GBPm)
before based on pre-tax profit
tax before the impact
of certain costs or
incomes that derive
from events or transactions
that fall outside
the normal activities
of the Group, and
are excluded by virtue
of their size and
nature in order to
reflect management's
view of the performance
of the Group.
--------------- -----------------------------
Underlying
PBT 96.4 84.5
Non-underlying
items -1 -4.9 3
-------- ---------- ------------
PBT 95.4 79.6
-------------------------------------------------------------------------- -------- ---------- ------------
Underlying Underlying profit Underlying FY17 FY18 Note
profit after tax (PAT) is PAT (GBPm)
after based on post tax
tax profit before the
impact of certain
costs or incomes that
derive from events
or transactions that
fall outside the normal
activities of the
Group, and are excluded
by virtue of their
size and nature in
order to reflect
management's
view of the performance
of the Group.
--------------- -----------------------------
Underlying
PAT 76.3 67.5
Non-underlying
items -1 -4.9
-------- ---------- ------------
PAT 75.4 62.6
-------------------------------------------------------------------------- -------- ---------- ------------
Underlying Underlying total tax Underlying FY17 FY18 Note
total expense is based on total tax
tax expense the statutory tax expense
expense for the period (GBPm)
(being the net of
current and deferred
tax) before the impact
of certain costs of
incomes that derive
from events or transactions
that fall outside
the normal activities
of the Group, and
are excluded by virtue
of their size and
nature in order to
reflect management's
view of the performance
of the Group.
--------------- -----------------------------
Underlying
tax expense -20 -17
Non-underlying
items - 0.2 3,8
-------- ---------- ------------
Tax expense -20 -16.8
-------------------------------------------------------------------------- -------- ---------- ------------
Working Working capital movement Net working FY17 FY18 Note
capital is a measure of the capital
cash required by the (GBPm) Movement
business to fund its
inventory, receivables
and payables. The
change year on year
reflects the cash
in/outflow in relation
to changes in the
working capital cycle
excluding Non-underlying
items. The change
in working capital
is a key component
of the free cash flow
measure of the Group.
--------------- -----------------------------
Net working
capital -2.3 2.9
Being:
Increase
in trade
and other
receivables -8.9 -6 CFS
Increase
in inventories -5 -4.1 CFS
Increase
in trade
and other
payables 11.5 11.8 CFS
Excluding
movement
in payables
relating
to Non-underlying
items -2.4
Decrease
in provisions 0.1 1.1 CFS
Excluding
movement
in provision
relating
to -0.9
-------- ---------- ------------
Non-underlying
items
-------- --------- ------------
Net working
capital -2.3 -0.4
CFS = Consolidated Statement
of Cash Flows
Net working FY17 FY18 Note
capital
Receivables 69.7 74.8
Inventory 56.4 60.5
Trade and
other receivables
(incl Corporation
Tax) -211.6 -222.1
Provisions -0.5 -0.8
Non-current
provisions -1.4 -2.2
-------- ---------- ------------
Net working
capital -87.4 -89.8
-------------------------------------------------------------------------- -------- ---------- ------------
Omni Revenue net of discounts (GBPm) FY17 FY18 Note
channel and VAT from core
Revenue online, sales, subscriptions
and order to store.
51.4 29.4
-------------------------------------------------------------------------- -------- ---------- ------------
Underlying Earnings before interest (GBPm) FY17 FY18 Note
EBIT and tax agreed to
operating profit relating
to underlying trading
--------------- -----------------------------
Operating
profit relating
to Underlying
trading
(EBIT) 100.9 88.8
-------------------------------------------------------------------------- -------- ---------- ------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FR PGUGGAUPRPUG
(END) Dow Jones Newswires
May 22, 2018 02:01 ET (06:01 GMT)
1 Year Pets At Home Chart |
1 Month Pets At Home Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
